Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 42, No. 1, 2000   

Free Abstract     Article (References)     Article (PDF 285 KB)     

MDMA (Methylenedioxymethamphetamine)
Editor: A.C. Parrott, London


Paper

Potential Human Neurotoxicity of MDMA ('Ecstasy'): Subjective Self-Reports, Evidence from an Italian Drug Addiction Centre and Clinical Case Studies
Fabrizio Schifano

Addiction Treatment Unit No. 1, Local Health Unit No. 16, Padova, Italy; St. George's Hospital Medical School, Master's School of Addictive Behaviours, University of London, UK

Address of Corresponding Author

Neuropsychobiology 2000;42:25-33 (DOI: 10.1159/000026667)


 goto top of page Key Words

  • MDMA
  • Ecstasy abuse
  • Psychopathological consequences
  • Epidemiology

 goto top of page Abstract

The present paper attempts to give an updated overview of the magnitude of the phenomenon of ecstasy abuse in Italy and other European countries. It gives an account of some clinical case studies and of a larger-scale report on polydrug (including MDMA) consumers attending our Public Health Addiction Treatment Unit in recent years, with a view to clarifying the characteristics and psychopathological consequences (mainly depression, psychotic disorders, cognitive disturbances, bulimic episodes, impulse control disorders, panic disorders, social phobia) of MDMA consumption. Longer-term, larger-dose (acute or cumulative) MDMA consumers were found to be at high risk of developing these psychopathological disturbances. A tentative description of certain personological dimensions of ecstasy consumers is also given (the novelty-seeking dimension was characteristic of those who occasionally experimented with the drug) while those who ingested larger quantities revealed low harm avoidance scores). Results are discussed in the light of the complex and different methodological issues arising from this kind of study, in which MDMA is far from being the only drug of abuse.

Copyright © 2000 S. Karger AG, Basel


 goto top of page Author Contacts

F. Schifano, MD
SERT No. 1, Via Berchet, 20
I-35100 Padova (Italy)
Tel. +39 049 8215322, Fax +39 049 8215318
E-Mail schifano@ux1.unipd.it


 goto top of page Article Information

Number of Print Pages : 9
Number of Figures : 0, Number of Tables : 4, Number of References : 52

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 10867553)
Download Citation



This journal is part of the first subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their research paper editing service.





copyright  © 2008 S. Karger AG, Basel